Macrolide resistance mechanisms in Gram-positive cocci

International Journal of Antimicrobial Agents

Volumn 18, Issue SUPPL.1, 2001, Pages 25-28

  Pechere J C ^a  

^a UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

Author keywords

Gram positive bacteria; Macrolides; Resistance; Staphylococci; Streptococci; Streptococcus pneumoniae

Indexed keywords

ANTIINFECTIVE AGENT; ERYTHROMYCIN; METHYLTRANSFERASE;

ANTIBIOTIC RESISTANCE; DRUG EFFECT; ENZYMOLOGY; GENETICS; GRAM POSITIVE COCCI; HUMAN; METABOLISM; MULTIDRUG RESISTANCE; REVIEW; TRANSPORT AT THE CELLULAR LEVEL;

ANTI-BACTERIAL AGENTS; BIOLOGICAL TRANSPORT; DRUG RESISTANCE, BACTERIAL; DRUG RESISTANCE, MULTIPLE; ERYTHROMYCIN; GRAM-POSITIVE COCCI; HUMANS; METHYLTRANSFERASES;

EID: 0002014529     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0924-8579(01)00407-1     Document Type: Article

References (34)

1. Retsema J, Girard A, Schelky W, et al. Spectrum and mode of action of azithromycin (CP-62 993), a new 15-membered-ring macrolide with improved potency against Gram-negative organisms. Antimicrob Agents Chemother 1987;32:1939-47.
2. Chabbert YA. Antagonisme in vitro entre l'érythromycine et la spiramycine. Ann Inst Pasteur 1956;90:787-90.
3. Tanaka T, Weisblum B. Systematic difference in the methylation of ribosomal ribonucleic acid from Gram-positive and Gram-negative bacteria. J Bacteriol 1975;123:771-4.
4. Leclercq R, Courvalin P. Bacterial resistance to macrolide, lincosamide, and streptogramin antibiotics by target modification. Antimicrob Agents Chemother 1991;35:1267-72.
5. Lai CJ, Weisblum B. Altered methylation of ribosomal RNA in an erythromycin-resistant strain of Staphylococcus aureus. Proc Natl Acad Sci USA 1971;68:856-60.
6. Zhong P, Cao Z, Hammond R, et al. Induction of ribosome methylation in MLS-resistant Streptococcus pneumoniae by macrolides and ketolides. Microb Drug Resist 1999;5:183-8.
7. Kamimiya S, Weisblum B. Induction of ermSV by 16-membered ring macrolide antibiotics. Antimicrob Agents Chemother 1997;41:530-4.
8. Khan SA, Nawaz MS, Khan AA, Cerniglia CE. Simultaneous detection of erythromycin-resistant methylase genes ermA and ermC from Staphylococcus species by multiplex-PCR. Mol Cell Probes 1999;13:381-7.
9. Berryman DI, Rood JI. Cloning and hybridization analysis of ermP, macrolide-lincosamide-streptogramin B resistance determinant from Clostridium perfringens. Antimicrob Agents Chemother 1989;33:1346-53.
10. Hachler H, Berger-Bachi B, Kayser FH. Genetic characterization of a Clostridium difficile erythromycin-clindamycin resistance determinant that is transferable to Staphylococcus aureus. Antimicrob Agents Chemother 1987;31:1039-45.
11. Brisson-Noel A, Arthur M, Courvalin P. Evidence for natural gene transfer from Gram-positive cocci to Escherichia coli. J Bacteriol 1988;170:1739-45.
12. Seppälä H, Skurnik M, Soini H, Roberts MC, Houviene P. A novel erythromycin resistance methylase gene (ermTR) in Streptococcus pyogenes. Antimicrob Agents Chemother 1998;42:257-62.
13. Nicola FG, McDougal LK, Biddle JW, Tenover FC. Characterization of erythromycin-resistant isolates of Staphylococcus aureus recovered in the United States from 1958 through 1969. Antimicrob Agents Chemother 1998;42:3024-7.
14. Lampson BC, Parisi JT. Naturally occurring Staphylococcus epidermidis plasmid expressing constitutive macrolide-lincosamide-streptogramin B resistance contains a deleted attenuator. J Bacteriol 1986;166:479-83.
15. Rasmussen JL, Odelson DA, Macrina FL. Complete nucleotide sequence and transcription of ermF, a macrolide-lincosamide-streptogramin B resistance determinant from Bacteroides fratgilis. J Bacteriol 1986;168:523-33.
16. Farrow KA, Lyras Rood JI. The macrolide-lincosamide-streptogramin B resistance determinant in Clostridium difficile 630 contains two erm(B) genes. Antimicrob Agents Chemother 2000;44:411-3.
17. Courvalin P, Depardieu F. Ochsner Clinical Symposium on Resistance and the Use of Antimicrobial Therapy, www.librainitiative. com.
18. Nikaido H. Prevention of drug access to bacterial targets: permeability barriers and active efflux. Science 1994;264:382-8.
19. Nakae T. Outer-membrane permeability of bacteria. Crit Rev Microbiol 1986;13:1-62.
20. Goldman RC, Capobianco JO. Role of energy-dependent efflux pump in plasmid pNE24-mediated resistance to 14- and 15-membered macrolides in Staphylococcus epidermidis. Antimicrob Agents Chemother 1990;34:1973-80.
21. Aprin C, Canron MH, Noury P, Quentin C. Emergence of mefA and mefE genes in β-haemolytic streptococci. J Antimicrob Chemother 1999;44:133-4.
22. Clancy J, Dib-Hajj F, Petitpas JW, Yuan W. Cloning and characterization of novel macrolide efflux gene, mefA, from Streptococcus agalactiae. Antimicrob Agents Chemother 1997;42:2719-23.
23. Kataja J, Seppälä H, Skurnik M, Sarkkinen H, Huovinen P. Different erythromycin mechanisms in group C and group G streptococci. Antimicrob Agents Chemother 1998;42:1493-4.
24. Piddock LJ. Mechanisms of fluoroquinolone resistance: an update, 1994-1998. Drugs 1999;58(Suppl. 2): 11-8.
25. Johnston NJ, de Azevedo JC, Kellner JD, Low DE. Prevalence and characterization of the mechanisms of macrolide, lincosamide, and streptogramin resistance in isolates of Streptococcus pneumoniae. Antimicrob Agents Chemother 1998;42:2425-6.
26. Latini L, Ronchettti MP, Merolla R, et al. Prevalence of mefE, erm and tet(M) genes in Streptococcus pneumoniae strains from central Italy. Int J Antimicrob Agents 1999;13:29-33.
27. Luna VA, Coates P, Eady EA, Cove JH, Nguyen TT, Roberts RC. A variety of Gram-positive bacteria carry mobile mef genes. J Antimicrob Chemother 1999;44:19-25.
28. Matsouka M, Endou K, Saitoh S, Katoh M, Nakajima Y. A mechanism of resistance to partial macrolide and streptogramin B antibiotics in Staphylococcus aureus clinically isolated in Hungary. Bio Bull Pharm 1995;18:1482-6.
29. Lampson BC, von David W, Parisi JT. Novel mechanism of plasmid-mediated erythromycin resistance by pNE24 from Staphylococcus epidermidis. Antimicrob Agents Chemother 1986;30:653-8.
30. Marshall NJ, Piddock LJ. Antibacterial efflux systems. Microbiologica 1997;13:285-300.
31. Wondrack L, Massa M, Yang BV, Sutcliffe J. Clinical strain of Staphylococcus aureus inactivates and causes efflux of macrolides. Antimicrob Agents Chemother 1996;40:992-8.
32. Leclercq R, Brisson-Noel A, Duval J, Courvalin P. Phenotypic expression and heterogeneity of lincosamide inactivation in Staphylococcus species. Antimicrob Agents Chemother 1987;31:1887-91.
33. Lina G, Quaglia A, Reverdy ME, Leclercq R, Vansenesch F, Etienne J. Distribution of genes encoding resistance to macrolides, lincosamides, and streptogramins among staphylococci. Antimicrob Agents Chemother 1999;43:1062-6.
34. Seppälä H, Klaukka T, Vuopio-Varkila J, et al. The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococcus in Finland. N Engl J Med 1997;337:441-6.